Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer

被引：0
|
作者：
Shaymaa Bahnassy
Hariprasad Thangavel
Maram Quttina
Ashfia Fatima Khan
Dhanya Dhanyalayam
Joan Ritho
Samaneh Karami
Jing Ren
Tasneem Bawa-Khalfe
机构：
[1] University of Houston,Center for Nuclear Receptors & Cell Signaling, Department of Biology & Biochemistry
[2] University of Houston,Department of Pharmacy Practice and Translational Research, College of Pharmacy
[3] Stanford University,Department of Biology
[4] University of Missouri,Center for Precision Medicine, Department of Medicine
来源：
Cell Communication and Signaling | / 18卷
关键词：
HR+ breast cancer; Endocrine resistance; Androgen receptor; SUMO; Enzalutamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
    Bahnassy, Shaymaa
    Thangavel, Hariprasad
    Quttina, Maram
    Khan, Ashfia Fatima
    Dhanyalayam, Dhanya
    Ritho, Joan
    Karami, Samaneh
    Ren, Jing
    Bawa-Khalfe, Tasneem
    CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
  • [2] Sumo-modified androgen receptors support the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
    Bawa-Khalfe, Tasneem
    Bahnassy, Shaymaa
    Thangavel, Hariprasad
    Quttina, Maram
    Khan, Ashfia Fatima
    Dhanyalayam, Dhanya
    Ritho, Joan
    Karami, Samaneh
    Ren, Jing
    CANCER RESEARCH, 2021, 81 (04)
  • [3] New Targets in Endocrine-Resistant Hormone Receptor-Positive Breast Cancer
    Kennedy, Laura C.
    Mayer, Ingrid A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 511 - 521
  • [4] Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic Hormone Receptor-Positive Breast Cancer
    Sarma, Maithreyi
    Abdou, Yara
    Dhakal, Ajay
    Gandhi, Shipra
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2020, 14
  • [5] Androgen Receptor in Hormone Receptor-Positive Breast Cancer
    Khan, Ashfia Fatima
    Karami, Samaneh
    Peidl, Anthony S.
    Waiters, Kacie D.
    Babajide, Mariam Funmi
    Bawa-Khalfe, Tasneem
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [6] Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer
    Nicholson, RI
    Hutcheson, IR
    Harper, ME
    Knowlden, JM
    Barrow, D
    McClelland, RA
    Jones, HE
    Wakeling, AE
    Gee, JMW
    ENDOCRINE-RELATED CANCER, 2001, 8 (03) : 175 - 182
  • [7] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    Anishka D’Souza
    Darcy Spicer
    Janice Lu
    Journal of Hematology & Oncology, 11
  • [8] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    D'Souza, Anishka
    Spicer, Darcy
    Lu, Janice
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [9] Ethoxy mansonone G as an anticancer agent in estrogen receptor-positive and endocrine-resistant breast cancer
    Chonsut, Piriya
    Mahalapbutr, Panupong
    Pradubyat, Nalinee
    Chavasiri, Warinthorn
    Wonganan, Piyanuch
    Ketchart, Wannarasmi
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (12) : 1839 - 1853
  • [10] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian Li
    Xu Feng-Rui
    Jiang Ze-Fei
    中华医学杂志(英文版), 2020, 133 (19) : 2338 - 2345
12345